2019YFC1005200/National Key Technology R&D Program of China[Grants and Funding] - Search Results

Year	Number of Results
2020	1
2021	3
2022	2
2023	1
2024	1

1

Progress in the management of ovarian granulosa cell tumor: A review.

Li J, Chu R, Chen Z, Meng J, Yao S, Song K, Kong B. Li J, et al. Acta Obstet Gynecol Scand. 2021 Oct;100(10):1771-1778. doi: 10.1111/aogs.14189. Epub 2021 Jul 16. Acta Obstet Gynecol Scand. 2021. PMID: 34027996 Free article.

2

Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma.

Lv M, Chen P, Bai M, Huang Y, Li L, Feng Y, Liao H, Zheng W, Chen X, Zhang Z. Lv M, et al. Cancers (Basel). 2022 Dec 15;14(24):6210. doi: 10.3390/cancers14246210. Cancers (Basel). 2022. PMID: 36551694 Free PMC article. Review.

3

Targeting Cancer Metabolism Plasticity with JX06 Nanoparticles via Inhibiting PDK1 Combined with Metformin for Endometrial Cancer Patients with Diabetes.

Yang X, Cheng Y, Zhou J, Zhang L, Li X, Wang Z, Yin S, Zhai L, Huang T, Wu X, Shen B, Dong Y, Zhao L, Chi Y, Jia Y, Wang J, He Y, Dong X, Xiao H, Wang J. Yang X, et al. Adv Sci (Weinh). 2022 Mar;9(8):e2104472. doi: 10.1002/advs.202104472. Epub 2022 Jan 22. Adv Sci (Weinh). 2022. PMID: 35064767 Free PMC article.

4

Carbon nanoparticles combined with indocyanine green for sentinel lymph node detection in endometrial carcinoma.

Liang S, Wang Z, Chen J, Yang X, Liang X, Sun X, Li X, Zhou R, Li Y, Wang J. Liang S, et al. J Surg Oncol. 2021 Sep;124(3):411-419. doi: 10.1002/jso.26518. Epub 2021 Jun 4. J Surg Oncol. 2021. PMID: 34086291

5

Exploration of eMSCs with HA-GEL system in repairing damaged endometrium after endometrial cancer with fertility-sparing treatment.

Liu W, Hao M, Xu Y, Ren X, Hu J, Wang L, Chen X, Lv Q. Liu W, et al. Cell Tissue Res. 2023 Nov;394(2):379-392. doi: 10.1007/s00441-023-03831-0. Epub 2023 Sep 28. Cell Tissue Res. 2023. PMID: 37759141

6

Phosphorylation of IDH1 Facilitates Progestin Resistance in Endometrial Cancer.

Li J, Qin Z, Li Y, Huang B, Xiao Q, Chen P, Luo Y, Zheng W, Zhang T, Zhang Z. Li J, et al. Adv Sci (Weinh). 2024 Apr 6:e2310208. doi: 10.1002/advs.202310208. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 38582508

Pharmacological inhibition of p38 or focal adhesion signaling sensitizes endometrial cancer cells to progestin in vivo. The study reveals p38-dependent pT77-IDH1 as a key mediator of progestin resistance and a promising target for improving the efficacy of progestin therap …

Pharmacological inhibition of p38 or focal adhesion signaling sensitizes endometrial cancer cells to progestin in vivo. The study reveals p3 …

7

The efficiency of a combined injection technique for sentinel lymph node mapping in intermediate-high-risk endometrial cancer.

Wang Q, Wang B, Wang L, Xue Y, Shan W, Luo X, Wang C, Chen X. Wang Q, et al. J Surg Oncol. 2021 Dec;124(8):1551-1560. doi: 10.1002/jso.26666. Epub 2021 Sep 8. J Surg Oncol. 2021. PMID: 34496048

8

Positive peritoneal cytology is an independent risk factor in endometrial cancer.

Dong Y, Wang Z, Wang J. Dong Y, et al. J Obstet Gynaecol Res. 2020 Sep;46(9):1842-1850. doi: 10.1111/jog.14361. Epub 2020 Jul 8. J Obstet Gynaecol Res. 2020. PMID: 32643298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year